Incorporating media data into a model of infectious disease transmission.
Communicable Disease Control
/ methods
Communicable Diseases
Communications Media
/ trends
Disease Outbreaks
/ prevention & control
Epidemics
/ prevention & control
Forecasting
Hemorrhagic Fever, Ebola
/ epidemiology
Humans
Incidence
Influenza, Human
/ epidemiology
Mass Media
/ trends
Mexico
Probability
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
05
2018
accepted:
17
01
2019
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
4
12
2019
Statut:
epublish
Résumé
Understanding the effect of media on disease spread can help improve epidemic forecasting and uncover preventive measures to slow the spread of disease. Most previously introduced models have approximated media effect through disease incidence, making media influence dependent on the size of epidemic. We propose an alternative approach, which relies on real data about disease coverage in the news, allowing us to model low incidence/high interest diseases, such as SARS, Ebola or H1N1. We introduce a network-based model, in which disease is transmitted through local interactions between individuals and the probability of transmission is affected by media coverage. We assume that media attention increases self-protection (e.g. hand washing and compliance with social distancing), which, in turn, decreases disease model. We apply the model to the case of H1N1 transmission in Mexico City in 2009 and show how media influence-measured by the time series of the weekly count of news articles published on the outbreak-helps to explain the observed transmission dynamics. We show that incorporating the media attention based on the observed media coverage of the outbreak better estimates the disease dynamics from what would be predicted by using media function that approximate the media impact using the number of cases and rate of spread. Finally, we apply the model to a typical influenza season in Washington, DC and estimate how the transmission pattern would have changed given different levels of media coverage.
Identifiants
pubmed: 30716139
doi: 10.1371/journal.pone.0197646
pii: PONE-D-18-13239
pmc: PMC6361417
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0197646Déclaration de conflit d'intérêts
The authors declare the following interests: LK, SF, and NM are employed by the commercial company, The Charles Stark Draper Laboratory (https://www.draper.com/). There are no patents, products in development, or marketed products to declare related to this study. This does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.
Références
PLoS Comput Biol. 2007 May;3(5):e85
pubmed: 17480117
PLoS One. 2011;6(8):e23084
pubmed: 21826228
PLoS Curr. 2015 May 15;7:
pubmed: 26075140
PLoS One. 2015 Nov 03;10(11):e0141423
pubmed: 26528909
Science. 1999 Oct 15;286(5439):509-12
pubmed: 10521342
Emerg Infect Dis. 2004 Apr;10(4):587-92
pubmed: 15200846
BMC Infect Dis. 2010 Jul 28;10:222
pubmed: 20663229
Int J Infect Dis. 2011 Nov;15(11):e781-6
pubmed: 21855383
Influenza Other Respir Viruses. 2013 Sep;7(5):738-49
pubmed: 23043518
Sci Rep. 2015 Jan 16;5:7838
pubmed: 25592757
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
Math Biosci. 2011 Apr;230(2):87-95
pubmed: 21296092
Lancet. 2010 Oct 9;376(9748):1261-71
pubmed: 20933263
J Dyn Differ Equ. 2008;20(1):31-53
pubmed: 32214759
MMWR Morb Mortal Wkly Rep. 2009 Jun 5;58(21):585-9
pubmed: 19498336
PLoS Med. 2008 Jul 8;5(7):e151
pubmed: 18613747
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82
pubmed: 21342903
Science. 2013 Oct 4;342(6154):47-9
pubmed: 24092718
BMC Public Health. 2014 Apr 17;14:376
pubmed: 24742139
PLoS Med. 2011 May;8(5):e1000436
pubmed: 21629683
Vaccine. 2013 Oct 1;31(42):4860-6
pubmed: 23954379
J R Soc Interface. 2015 Mar 6;12(104):20141105
pubmed: 25589575
BMC Infect Dis. 2015 Jan 23;15:21
pubmed: 25616673
Lancet. 2003 May 3;361(9368):1519-20
pubmed: 12737864
Vaccine. 2012 Oct 19;30(47):6700-5
pubmed: 22944629